Drug Type Small molecule drug |
Synonyms UCM-19286 |
Target |
Action inhibitors |
Mechanism NPM1 inhibitors(Nucleophosmin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | Spain | 12 Jun 2025 | |
Acute myeloid leukemia with mutated NPM1 | Preclinical | Spain | 14 May 2025 |